Quantcast

Latest Metaplasia Stories

2010-04-12 11:13:05

Atrophic gastritis and intestinal metaplasia are two important precursory lesions in the process of intestinal type gastric cancer. However, the precise mechanism of the progression of these two lesions is still unclear, a few studies have investigated the risk of host gene polymorphism on the atrophic gastritis and intestinal metaplasia, but all of them are limited by their one-time point screen. A research article to be published on April 14, 2010 in the World Journal of Gastroenterology...

2010-02-10 09:07:49

Gastric cancer remains a significant problem globally. The relationship between intestinal metaplasia (IM) and gastric cancer has always been controversial. Generally IM is divided into subtypes on the basis of histochemical characteristics; however, this classification is confusing. A new classification of IM is needed in order to follow up patients selectively. A research team led by Prof Zhang of the Department of Pathology, Qilu Hospital of Shandong University first proposed the...

2009-06-03 12:00:00

Radiofrequency ablation is durable after 2 years, compares favorably with endoscopic resection for advanced disease, and reduces the risk for cancer progression SUNNYVALE, Calif., June 3 /PRNewswire/ -- Results from a number of clinical trials were presented during the Digestive Disease Week (DDW) in Chicago this week, revealing new outcomes data related to endoscopic radiofrequency ablation using the HALO ablation system for eradicating a pre-cancerous esophageal condition known as...

2009-06-01 17:00:00

Large multi-center trial conducted in a community practice setting demonstrates comparable outcomes as trials conducted in predominantly tertiary academic centers SUNNYVALE, Calif., June 1 /PRNewswire/ -- Clinical trial results presented at the Digestive Disease Week in Chicago today reveal that endoscopic radiofrequency ablation performed in a community practice setting is safe and effective for eradicating a pre-cancerous esophageal condition known as Barrett's esophagus. The study is...

2009-05-15 08:39:07

Researchers find electronic coding overestimates prevalence of Barrett's esophagusIn a review of more than 2,000 patients coded for Barrett's esophagus, electronic diagnosis overestimated the prevalence of the disease according to researchers in California. They found that only 61.9 percent of patients assigned a billing diagnosis code for Barrett's esophagus actually had Barrett's esophagus after a manual record review. The study evaluated the accuracy of diagnostic codes for Barrett's...

2008-10-01 12:00:07

SAN DIEGO, Oct. 1 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (BULLETIN BOARD: SCIE) , a San Diego-based medical device company, today announced that it has shipped its non-invasive WavSTAT(R) Optical Biopsy System to the University of Southern California to demonstrate the clinical value of the Optical Biopsy System as an adjunctive tool to improve clinical sensitivity in identifying dysplasia or cancer in the esophagus. This marks the final phase of a study which has been conducted...

2008-09-16 15:00:11

SAN DIEGO, Sept. 16 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (BULLETIN BOARD: SCIE) , a San Diego-based medical devices company, today announced that it is shipping its WavSTAT(R) Optical Biopsy System to the Mayo Clinic and to the University of California San Diego/VA to complete a study at each site. The purpose of this study is to demonstrate the clinical value of the Optical Biopsy System as an adjunctive tool to improve an endoscopists' clinical sensitivity in identifying...

2008-07-21 00:00:15

SUNNYVALE, Calif., July 21 /PRNewswire/ -- BARRX Medical, Inc. today announced that 98.4 percent of patients having a precancerous condition of their esophagus called Barrett's esophagus were free of the disease 2.5 years after non-surgical, endoscopic treatment with the HALO ablation system. The results were published this month in Gastrointestinal Endoscopy, a leading scientific publication for gastrointestinal physicians and researchers. Barrett's esophagus develops as a result of...

2007-05-20 21:00:19

SUNNYVALE, Calif., May 20 /PRNewswire/ -- BARRX Medical, Inc. today announced that 98.4% of patients with Barrett's esophagus treated with the HALO Ablation System have no residual Barrett's esophagus tissue after a follow up period of more than two and a half years. The presentation of these long-term clinical trial results was made at the Digestive Disease Week (DDW) meeting this week, an international meeting of more than 16,000 gastrointestinal physicians and researchers, held in...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related